These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 27607068)

  • 1. [Treatment Options for Executive Dysfunction].
    Müller SV
    Fortschr Neurol Psychiatr; 2016 Sep; 84(9):542-9. PubMed ID: 27607068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive dysfunction.
    Rabinovici GD; Stephens ML; Possin KL
    Continuum (Minneap Minn); 2015 Jun; 21(3 Behavioral Neurology and Neuropsychiatry):646-59. PubMed ID: 26039846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Executive functioning in unipolar depression: a review].
    Fossati P; Ergis AM; Allilaire JF
    Encephale; 2002; 28(2):97-107. PubMed ID: 11972136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive dysfunction following traumatic brain injury: neural substrates and treatment strategies.
    McDonald BC; Flashman LA; Saykin AJ
    NeuroRehabilitation; 2002; 17(4):333-44. PubMed ID: 12547981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychobehavioral disorders in severe dementia].
    Derouesné C
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S5-13. PubMed ID: 15899600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of inhibition in obsessional-compulsive disorders].
    Dupuy M; Rouillon F; Bungener C
    Encephale; 2013 Feb; 39(1):44-50. PubMed ID: 23095598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study.
    Elgamal S; McKinnon MC; Ramakrishnan K; Joffe RT; MacQueen G
    Psychol Med; 2007 Sep; 37(9):1229-38. PubMed ID: 17610766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention and executive functions in remitted major depression patients.
    Paelecke-Habermann Y; Pohl J; Leplow B
    J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal executive function syndromes in children.
    Powell KB; Voeller KK
    J Child Neurol; 2004 Oct; 19(10):785-97. PubMed ID: 15559894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Executive control functions and neuropsychiatric disorders -- perspectives for research und clinical practice].
    Kaiser S; Mundt C; Weisbrod M
    Fortschr Neurol Psychiatr; 2005 Aug; 73(8):438-50. PubMed ID: 16052438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between acquired impairments of executive function and behaviour change in adults with Down syndrome.
    Adams D; Oliver C
    J Intellect Disabil Res; 2010 May; 54(5):393-405. PubMed ID: 20367747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acupuncture and computer-assisted cognitive training for post-stroke attention deficits: study protocol for a randomized controlled trial.
    Huang J; McCaskey MA; Yang S; Ye H; Tao J; Jiang C; Schuster-Amft C; Balzer C; Ettlin T; Schupp W; Kulke H; Chen L
    Trials; 2015 Dec; 16():546. PubMed ID: 26631161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive remediation therapy for mood disorders: rationale, early evidence, and future directions.
    Bowie CR; Gupta M; Holshausen K
    Can J Psychiatry; 2013 Jun; 58(6):319-25. PubMed ID: 23768259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy.
    Millar D; Griffiths P; Zermansky AJ; Burn DJ
    Mov Disord; 2006 Feb; 21(2):199-207. PubMed ID: 16200534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disorders of executive functions. Diagnosis and treatment].
    Delgado-Mejía ID; Etchepareborda MC
    Rev Neurol; 2013 Sep; 57 Suppl 1():S95-103. PubMed ID: 23897161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Secondary benefits of cognitive rehabilitation for a chronic ethylic patient: effects on disorder consciousness, motivation, and global therapeutic cooperation].
    Siccardi L; Vautel-Pons D; dos Santos MT; Camus N; Louchart de la Chapelle S
    Encephale; 2014 Jun; 40(3):263-70. PubMed ID: 23928068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.